Efficacy and Safety of FLEXIPORT Implantable Port in Chemotherapeutic Treatments
NCT: NCT07856745 · COMPLETED
Brief Summary
The goal of this clinical trial is to assess, in a clinical setting, the efficacy and the safety of FLEXIPORT, a totally implantable venous access device (TIVAD) designed to provide a repeated access to the vascular system, in patients with malignant diseases requiring central venous access for administration of chemotherapeutic treatments. The main question it aims to answer is what is the success rate of the device in providing vascular access, with the success rate defined as proportion of participants with a functioning device at 180 days post-implantation or at the time of removal, if the latter occurred for reasons other than adverse event or device deficiency.
Frequently Asked Questions
What is Efficacy and Safety of FLEXIPORT Implantable Port in Chemotherapeutic Treatments?
Efficacy and Safety of FLEXIPORT Implantable Port in Chemotherapeutic Treatments is a clinical trial registered under NCT07856745. Current status: COMPLETED.
What is the status of NCT07856745?
The current status of NCT07856745 (Efficacy and Safety of FLEXIPORT Implantable Port in Chemotherapeutic Treatments) is: COMPLETED.
When did Efficacy and Safety of FLEXIPORT Implantable Port in Chemotherapeutic Treatments start?
Efficacy and Safety of FLEXIPORT Implantable Port in Chemotherapeutic Treatments started on 2024-04-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.